Intersect ENT, Inc.·4

Nov 2, 4:30 PM ET

Kowalski Christine R 4

4 · Intersect ENT, Inc. · Filed Nov 2, 2018

Insider Transaction Report

Form 4
Period: 2018-11-01
Kowalski Christine R
Chief Operations Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-11-01+80,00080,000 total
    Exercise: $29.28Exp: 2028-10-31Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]The vesting commencement date of the option is October 29, 2018. 25% of the shares subject to the option shall vest on October 29, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter over three (3) years.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT